Fabian Weykamp - Concepedia

Author

Fabian Weykamp

National Center for Tumor Diseases ORCID

Also Known As

F. Weykamp, Fabian Weykamp

Publications

799

Citations

H-Index

Concepts

All Affiliations

National Center for Tumor Diseases University Hospital Heidelberg Heidelberg University German Cancer Research Center Heidelberger Institut für Radioonkologie

About

Fabian Weykamp is an author at National Center for Tumor Diseases specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	198
2	Health Sciences	4	4	76
3	Engineering	1	1	41
4	Hepatology	1	1	23
5	Pathology	1	1	41

Fabian Weykamp

Publications

675

Citations

H-Index

Page 1

	Year	Citations
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial) Juliane Hörner‐Rieber, Tobias Förster, Adriane Hommertgen, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation MedicineOncologyRadiation TherapyIs Noninferior	2020	57
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients Laila König, Matthias Häfner, Sonja Katayama, Radiation Oncology	2020	56
Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer Jakob Liermann, Mustafa Syed, Edgar Ben‐Josef, Cancers EngineeringOncologic ImagingPathologyTarget Volume DefinitionPancreatic Cancer	2021	41
Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes Fabian Weykamp, Philipp Hoegen, Sebastian Klüter, Frontiers in Oncology	2021	40
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations Sebastian Regnery, Carolin Buchele, Fabian Weykamp, Frontiers in Oncology	2022	37
Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer Fabian Weykamp, Laila König, Katharina Seidensaal, Frontiers in Oncology	2020	36
Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung Philipp Hoegen, Clemens Lang, Sati Akbaba, Frontiers in Oncology	2020	31
Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk Laila König, P. Haering, Clemens Lang, Frontiers in Oncology	2020	26
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial Philipp Hoegen, K. S. Zhang, Eric Tonndorf‐Martini, Radiation Oncology	2022	25
SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes Sebastian Regnery, Carolin Buchele, Lars Piskorski, Radiotherapy and Oncology Dosimetry OutcomesMinimally Invasive ProcedureSurgical PathologySurgeryAnesthesiology	2022	24

Page 1